A carregar...
The clinical utility of lurasidone in schizophrenia: patient considerations
Lurasidone is a novel antipsychotic agent approved for the treatment of schizophrenia in a number of countries including the United Kingdom, other European countries, the United States, and Canada. In addition to full antagonist activity at the dopamine D(2) (Ki, 1 nM) and serotonin 5-HT(2A) (Ki, 0....
Na minha lista:
| Publicado no: | Neuropsychiatr Dis Treat |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4425313/ https://ncbi.nlm.nih.gov/pubmed/25995636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S68417 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|